Skip to main content

Table 7 Temporal trends of antimicrobial resistance in Escherichia coli by country

From: European multicenter study on antimicrobial resistance in bacteria isolated from companion animal urinary tract infections

Countrya

(Years)

AMC

3GC

FLU

CN

SXT

MDR

FullS

ORb

(95 % CI)c

P value

ORb

(95 % CI) c

P value

ORb

(95 % CI) c

P value

ORb

(95 % CI) c

P value

ORb

(95 % CI) c

P value

ORb

(95 % CI) c

P value

ORb

(95 % CI) c

P value

BE

(2010–13)

0.787

(0.646–0.960)

0.0180

-

-

-

0.749

(0.635–0.882)

0.0006

0.677

(0.507–0.904)

0.0081

0.796

(0.695–0.912)

0.0010

0.529 d

(0.393–0.712)

<0.0001

1.275 d

(1.127–1.442)

0.0001

DK

(2008–13)

0.698

(0.500–0.976)

0.0357

0.869

(0.646–1.169)

0.3533

0.742

(0.565–0.976)

0.0325

0.926

(0.620–1.384)

0.7086

0.793

(0.642–0.980)

0.0316

0.874

(0.615–1.242)

0.4528

1.396

(1.156–1.684)

0.0005

FR

(2010–13)

0.885

(0.780–1.005)

0.0606

0.859

(0.749–0.987)

0.0314

0.822

(0.727–0.928)

0.0016

0.938

(0.734–1.200)

0.6121

0.960

(0.853–1.080)

0.4997

0.901

(0.782–1.037)

0.1448

1.112

(1.002–1.233)

0.0456

DE

(2009–13)

1.029

(0.779–1.358)

0.8424

1.076

(0.805–1.438)

0.6211

1.185

(0.912–1.540)

0.2037

0.856

(0.520–1.409)

0.5397

1.040

(0.831–1.302)

0.7317

1.111

(0.801–1.541)

0.5295

0.941

(0.780–1.136)

0.5281

ELe

(2009–13)

1.534

(0.851–2.766)

0.1545

1.083

(0.586–2.003)

0.7992

0.924

(0.630–1.355)

0.6855

-

-

-

0.880

(0.596–1.301)

0.5229

-

-

-

-

-

-

IT

(2009–2013)

1.175

(0.844–1.637

0.3391)

1.017

(0.749–1.383)

0.9127

0.828

(0.629–1.090)

0.1784

1.007

(0.700–1.449)

0.9686

0.769

(0.582–1.016)

0.0645

1.065

(0.761–1.490)

0.7147

1.248

(0.953–1.634)

0.1076

NL

(2008–13)

1.108

(1.026–1.197)

0.0088

0.465

(0.402–0.539)

<0.0001

0.916

(0.841–0.999)

0.0464

0.682

(0.327–1.422)

0.3071

0.917

(0.859–0.978)

0.0083

0.380 d

(0.320–0.450)

<0.0001

1.648 d

(1494.–1.818)

<0.0001

PT

(2008–13)

1.139

(0.913–1.419)

0.2482

1.187

(0.945–1.492)

0.1411

1.029

(0.823–1.287)

0.8029

1.222

(0.899–1.660)

0.2010

1.087

(0.867–1.364)

0.4680

1.156

(0.898–1.488)

0.2601

0.797

(0.629–1.010)

0.0608

ES

(2010–13)

1.372

(0.855–2.201)

0.1899

1.551

(0.857–2.808)

0.1474

0.801

(0.529–1214)

0.2965

0.859

(0.467–1.578)

0.6238

0.752

(0.489–1.156)

0.1939

1.237

(0.677–2.258)

0.4897

0.944

(0.570–1.564)

0.8234

SE

(2008–13)

0.976

(0.915–1.041)

0.4569

-

-

-

0.980

(0.827–1.147)

0.8018

0.700

(0.562–0.872)

0.0015

0.961

(0.892–1.037)

0.3059

0.697

(0.493–0.985)

0.0407

1.035

(0.965–1.110)

0.3341

CH

(2008–13)

1.143

(0.905–1.445)

0.2621

1.116

(0.861–1.447)

0.4067

1.007

(0.841–1.205)

0.9426

1.493

(1.009–2.208)

0.0451

1.080

(0.901–1.294)

0.4050

1.189

(0.920–1.536)

0.1863

1.025

(0.877–1.197)

0.7594

UK

(2008–13)

1.075

(0.857–1.357)

0.5194

1.106

(0.873–1.400)

0.4041

0.945

(0.739–1.208)

0.6511

1.306

(0.792–2.155)

0.2952

0.972

(0.797–1.185)

0.7778

1.355

(0.954–1.925)

0.0892

1.154

(0.950–1.401)

0.1492

  1. AMC amoxicillin clavulanate, 3GC third generation cephalosporins, FLU fluoroquinolones, CN gentamicin, SXT trimethoprim/sulfamethoxazole, MDR multidrug-resistant, FullS fully-susceptible
  2. aBE, Belgium; DK, Denmark; FR, France; DE, Germany; EL, Greece; IT, Italy; NL, the Netherlands; PT, Portugal; ES, Spain; SE, Sweden; CH, Switzerland; UK, United Kingdom
  3. bOR, Odds ratio
  4. c95 % CI, 95 % Confidence interval
  5. dMDR and FullS temporal trends do not include resistance to 3GC for Belgium and CN for the Netherlands
  6. eData regarding the years 2010 and 2012 were excluded from Greece resistance trends analysis since less than ten isolates were tested in those years
  7. Statistically significant trends are highlighted in bold
Back to article page

BMC Veterinary Research

ISSN: 1746-6148

Contact us